Last reviewed · How we verify
Ketamine plus Midazolam
Ketamine plus Midazolam is a Small molecule drug developed by Zagazig University. It is currently FDA-approved.
At a glance
| Generic name | Ketamine plus Midazolam |
|---|---|
| Sponsor | Zagazig University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delivery Under Spinal Anesthesia (NA)
- A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder (PHASE3)
- Ketamine, SGB and Combination Treatment for TBI (PHASE2)
- Prospective IR-led Sedation Feasibility (PHASE1, PHASE2)
- Comparative Assessment of Oral Premedication Regimens in Pediatric Ambulatory Surgery (NA)
- Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients (NA)
- Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology (EARLY_PHASE1)
- Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketamine plus Midazolam CI brief — competitive landscape report
- Ketamine plus Midazolam updates RSS · CI watch RSS
- Zagazig University portfolio CI
Frequently asked questions about Ketamine plus Midazolam
What is Ketamine plus Midazolam?
Ketamine plus Midazolam is a Small molecule drug developed by Zagazig University.
Who makes Ketamine plus Midazolam?
Ketamine plus Midazolam is developed and marketed by Zagazig University (see full Zagazig University pipeline at /company/zagazig-university).
What development phase is Ketamine plus Midazolam in?
Ketamine plus Midazolam is FDA-approved (marketed).
Related
- Manufacturer: Zagazig University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing